TPG Capital finishes $1.9B purchase of Immucor
Blood-testing equipment maker Immucor Inc. said Friday it has completed a deal in which it will be acquired by the private investment firm TPG Capital for about $1.94 billion, or $27 per share.
Immucor, based in Norcross, Ga., said a tender offer to acquire all of its outstanding shares expired Thursday. About 87 percent of the shares — or 61.5 million — had been validly tendered and not withdrawn. TPG Capital then purchased, through an affiliate, additional shares at the same price paid in the tender offer.
Immucor's stock will stop trading on the Nasdaq Global Select Market. The company announced the deal in July.
Immucor sells automated testing systems to screen donated blood. The company also sells supplies for those systems. The company's sales have been hurt by the weak economy.